Clinical Trial Update: Ablation in Brugada Syndrome for the Prevention of VF [NA]

View source ↗

Summary

Clinical trial NCT02704416 evaluating ablation to prevent ventricular fibrillation in Brugada syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brugada Syndrome

Snippet

Sponsor: Pacific Rim Electrophysiology Research Institute | Conditions: Brugada Syndrome | NA | Status: COMPLETED